Stereotactic Staged Asymmetric Bilateral Radiofrequency Lesioning for Parkinson’s Disease
Stereotactic and Functional Neurosurgery · 2023
DOI: 10.1159/000534084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stereotactic and Functional Neurosurgery, 2023. Verfasst von Kostiantyn Kostiuk. Beteiligte Einrichtung: Department of Functional Neurosurgery and Neuromodulation, SI "Romodanov Neurosurgery Institute NAMS of Ukraine", Kyiv, Ukraine. Hauptthemen laut MEDLINE: Parkinson Disease, Subthalamic Nucleus, Deep Brain Stimulation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Parkinson’s disease (PD) is one of the most common neurodegenerative progressive disorders. Despite the dominance of neurostimulation technology, stereotactic lesioning operations play a significant role in the treatment of PD. The aim of the study was to evaluate the effectiveness and safety of staged bilateral asymmetric radiofrequency (RF) stereotactic lesioning in a highly selected group of PD patients. Material and Methods: A retrospective review of 418 consecutive patients undergoing stereotactic ablation for advanced PD at our institution revealed 28 patients who underwent staged asymmetric bilateral ablation. In this subset, after initial RF thalamotomy, contralateral pallidotomy was performed in 16 (57.1%) patients (group Vim-GPi), and contralateral lesion of the subthalamic nucleus (STN) was performed in 12 (32.9%) patients (group Vim-STN). The mean duration of disease before the first surgery was 9.9 ± 0.8 years. The mean interval between the two operations was 3.5 ± 0.4 years (range, 1–10 years); in the Vim-GPi group, it was 3.1 ± 0.4 years; and in the Vim-STN group, it was 4.3 ± 0.1 years. After the second operation, the long-term follow-up lasted from 1 to 8 years (mean 4.8 ± 0.5 years). All patients were evaluated 1 year after the second operation.
Results
One year after staged bilateral lesioning, the mean tremor score improved from baseline, prior to the first operation, from 19.8 to 3.8 (improvement of 81%), the overall mean rigidity score improved from 11.0 to 3.7 (improvement of 66%), and hypokinesia improved from 14.8 to 8.9 (improvement of 40%). One year after staged bilateral lesioning, the total UPDRS score improved in the Vim-GPi group by 47% in the OFF and 45.9% in the ON states. In the Vim-STN group, the total UPDRS score improved from baseline, prior to the first operation, by 44.8% in the OFF and 51.6% in the ON states. Overall, levodopa dose was reduced by 43.4%. Neurological complications were observed in 4 (14.3%) cases; among them, 1 (3.6%) patient had permanent events related to local ischemia after pallidotomy.
Conclusion
Staged asymmetric bilateral stereotactic RF lesioning can be a safe and effective method in highly selected patients with advanced PD, particularly where deep brain stimulation is not available or desirable. Careful identification and selection of patients for ablative surgery allow achieving optimal results in the treatment of PD with bilateral symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Functional Neurosurgery and Neuromodulation, SI "Romodanov Neurosurgery Institute NAMS of Ukraine", Kyiv, Ukraine.
Zitieren
APA
Kostiuk, K. (2023). Stereotactic Staged Asymmetric Bilateral Radiofrequency Lesioning for Parkinson’s Disease. Stereotactic and Functional Neurosurgery. https://doi.org/10.1159/000534084
Vancouver
Kostiuk K. Stereotactic Staged Asymmetric Bilateral Radiofrequency Lesioning for Parkinson’s Disease. Stereotactic and Functional Neurosurgery. 2023. doi:10.1159/000534084
BibTeX
@article{Kostiuk2023,
author = {Kostiuk, Kostiantyn},
title = {Stereotactic Staged Asymmetric Bilateral Radiofrequency Lesioning for Parkinson’s Disease},
journal = {Stereotactic and Functional Neurosurgery},
year = {2023},
doi = {10.1159/000534084}
}
EUVIMED